Filter News
Area of Research
- (-) Computational Biology (1)
- (-) Functional Materials for Energy (1)
- Advanced Manufacturing (6)
- Biology and Environment (38)
- Building Technologies (2)
- Clean Energy (75)
- Computational Engineering (1)
- Computer Science (8)
- Electricity and Smart Grid (1)
- Energy Sciences (1)
- Fusion and Fission (5)
- Fusion Energy (2)
- Materials (22)
- Materials for Computing (5)
- National Security (15)
- Neutron Science (8)
- Nuclear Science and Technology (5)
- Quantum information Science (1)
- Supercomputing (44)
News Type
News Topics
- (-) Artificial Intelligence (2)
- (-) Sustainable Energy (1)
- Biology (2)
- Biomedical (2)
- Buildings (1)
- Computer Science (1)
- Coronavirus (1)
- Decarbonization (1)
- Energy Storage (2)
- Environment (1)
- Frontier (1)
- Grid (1)
- High-Performance Computing (3)
- Machine Learning (1)
- Materials (2)
- Materials Science (1)
- Neutron Science (1)
- Simulation (1)
- Summit (1)
Media Contacts
![ORNL’s RapidCure improves lithium-ion electrode production by producing electrodes faster, reducing the energy necessary for manufacturing and eliminating the need for a solvent recycling unit. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2022-08/RapidCure_0.jpg?h=def3cf70&itok=BFENW6Cu)
Researchers at the Department of Energy’s Oak Ridge National Laboratory and their technologies have received seven 2022 R&D 100 Awards, plus special recognition for a battery-related green technology product.
![An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-06/frame1.png?h=d1cb525d&itok=51pwBWyP)
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.